Elizabeth, IL, United States of America

Boris Tabakoff

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Lohocla Research Corporation, Other. Active years: 1985-2021.

USPTO Granted Patents = 9 

% Patents Active = 88.9


 

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • Annapolis, MD (US) (1988)
  • Denver, CO (US) (2012)
  • Elizabeth, IL (US) (1985 - 2021)

Company Filing History:


Years Active: 1985-2021

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Boris Tabakoff

Introduction

Boris Tabakoff is a notable inventor based in Elizabeth, Illinois. He has made significant contributions to the field of therapeutic agents, holding a total of nine patents. His work primarily focuses on aminoquinoline compounds that are useful for treating various medical conditions.

Latest Patents

Among his latest patents are multifunctional aminoquinoline therapeutic agents. These aminoquinoline compounds are designed to treat chronic pain, addiction, and other conditions. The compounds are represented by a specific formula, with substituents defined in the patent specification.

Career Highlights

Boris has worked with Lohocla Research Corporation, where he has furthered his research and development efforts. His innovative approach has led to advancements in therapeutic solutions that address pressing health issues.

Collaborations

Some of his notable coworkers include Lawrence Snell and Paula L. Hoffman. Their collaboration has contributed to the success of various projects and patents.

Conclusion

Boris Tabakoff's work in the field of aminoquinoline compounds showcases his dedication to innovation and improving healthcare solutions. His contributions continue to impact the medical community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…